Analysis of the relationship of itgb3, fv, and fii gene polymorphism with the development of diabetic foot syndrome

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. There is a steady increase in the incidence of type 2 diabetes worldwide. One of the most formidable complications of this pathology is the development of diabetic foot syndrome, which is accompanied by up to 50% of cases of high amputations, disability, increased mortality and a decrease in the quality of life of patients.

The aim of the study: to study the prevalence of genotype and allele variants of the T1565C polymorphism of the ITGB3 gene, the G1691A polymorphism of the FV gene, and the G20210A polymorphism of the FII gene in patients with the development of diabetic foot syndrome, as well as in the control group living in the Trans-Baikal Territory.

Material and methods. Polymorphism T1565C of the ITGB3 gene, G1691A polymorphism of the FV gene, and G20210A polymorphism of the FII gene were studied by PCR methods in 100 apparently healthy individuals and 198 patients with a mixed form of diabetic foot syndrome. The statistical significance of differences was assessed using Pearson’s chi-square test.

Results. The T/T genotype of T1565C polymorphism of the ITGB3 gene among healthy individuals was found in 70%, among patients with diabetic foot – 60.3%. The T/C genotype of the studied polymorphism of the ITGB3 gene in the control group was recorded in 29%, in the group of patients in 37.7%. The C/C genotype was detected in 1% of healthy individuals and 2% of diabetic foot patients.

The G/G genotype of the G1691A polymorphism of the FV gene was observed in 97% of healthy individuals and in 94% of patients among patients. The G/A genotype was detected in 3% in the control group and in 6% in the group of diabetic foot patients. The homozygous A/A genotype was not registered in the studied groups.

The G/G genotype of the G20210A polymorphism of the FII gene was registered in 92% of healthy individuals and in 95.5% of patients with diabetic foot. The G/A genotype was detected in 8% of cases in the control group and 4.5% of cases among patients with diabetic foot. The homozygous A/A genotype was not detected in the examined groups.

Conclusion: we did not find significant differences in the frequency of occurrence of genotype variants and alleles of the studied polymorphisms of the ITGB3, FV, FII genes among healthy individuals and patients with diabetic foot living in the Trans-Baikal Territory.

Full Text

Restricted Access

About the authors

Natalya I. Troitskaya

Chita State Medical Academy

Email: troicachita@mail.ru
ORCID iD: 0000-0002-8973-753X

Associate Professor of the Department of Oncology Chita State Medical Academy, сandidate of Medical Sciences

Russian Federation, st. Gorky, 39a, Chita, 672000

Konstantin G. Shapovalov

Chita State Medical Academy

Author for correspondence.
Email: shkg26@mail.ru
ORCID iD: 0000-0002-3485-5176

Head of the Department of Anesthesiology, Resuscitation and Intensive Care, Chita State Medical Academy, doctor of Medical Sciences, Professor

Russian Federation, st. Gorky, 39a, Chita, 672000

References

  1. Шарофова М.У., Сагдиева Ш.С., Юсуфи С.Д. Сахарный диабет: современное состояние вопроса (ч. 1). Вестник Авиценны. 2019; 21 (3): 502–12. https://doi.org/10.25005/2074-0581-2019-21-3-502-512. [Sharofova M.U., Sagdieva Sh.S., Jusufi S.D. Diabetes mellitus: the current state of the issue (p. 1). Vestnik Avicenny. 2019; 21 (3): 502–12. https://doi.org/10.25005/2074-0581-2019-21-3-502-512. (in Russian)].
  2. Berbudi A., Rahmadika N., Tjahjadi A. I., Ruslami R. Type 2 diabetes and its impact on the immune system. Current diabetes reviews. 2020; 16 (5): 442. doi: 10.2174/1573399815666191024085838.
  3. Долгих Ю.А., Вербовой А.Ф., Галкин Р.А. Микрососудистые осложнения сахарного диабета (лекция). Эндокринология: Новости. Мнения. Обучение. 2019; 4 (29): 44–54. doi: 10.24411/2304-9529-2019-14006. [Dolgih Ju.A., Verbovoj A.F., Galkin R.A.. Microvascular complications of diabetes mellitus (lecture). Jendokrinologija: Novosti. Mnenija. Obuchenie. 2019; 4 (29): 44–54. doi: 10.24411/2304-9529-2019-14006 (in Russian)].
  4. Lavery L.A., Oz O.K., Bhavan K., Wukich D.K. Diabetic foot syndrome in the twenty-first century. Clinics in podiatric medicine and surgery. 2019; 36 (3): 355–9. doi: 10.1016/j.cpm.2019.02.002.
  5. Рундо А.И. Современные аспекты этиологии и патогенеза синдрома диабетической стопы. Новости хирургии. 2015; 1: 97–104. [Rundo A.I. Modern aspects of the etiology and pathogenesis of diabetic foot syndrome. Novosti hirurgii. 2015; 1: 97–104 (in Russian)].
  6. Муслимова Э.Ф. Ассоциация полиморфизмов генов NOS3 и ITGB3 c риском развития ишемической болезни сердца. Сибирский медицинский журнал. 2016; 2: 22–5. [Muslimova Je.F. Association of polymorphisms of the NOS3 and ITGB3 genes with the risk of developing coronary heart disease. Sibirskij medicinskij zhurnal. 2016; 2: 22–5 (in Russian)].
  7. Яковлева Е.В., Коняшина Н.И., Горгидзе Л.А., Сурин В.Л., Пшеничникова О.С., Полеводова О.А., Спирин М.В., Галстян Г.М., Зозуля Н.И. Наследственный дефицит фактора свертывания крови V: клинические наблюдения. Гематология и трансфузиология. 2019; 4: 489–503. https://doi.org/10.35754/0234-5730-2019-64-4-489-503. [Jakovleva E.V., Konjashina N.I., Gorgidze L.A., Surin V.L., Pshenichnikova O.S., Polevodova O.A., Spirin M.V., Galstjan G.M., Zozulja N.I. Hereditary coagulation factor V deficiency: clinical observations. Gematologija i transfuziologija. 2019; 4: 489–503. https://doi.org/10.35754/0234-5730-2019-64-4-489-503. (in Russian)].
  8. Duckers C., Simioni P., Rosing J., Castoldi E. Advances in understanding the bleeding diathesis in factor V defi ciency. Br. J. Haematol. 2009; 146 (1): 17–26. DOI: 10.1111 / j.1365-2141.2009.07708.x
  9. Колосков А.В., Чернова Е.В. Клиническое значение полиморфизма генов фактора V и протромбина. Гематология и трансфузиология. 2018; 3: 250–7. doi: 10.25837/HAT.2019.63.13.004. [Koloskov A.V., Chernova E.V. Clinical significance of factor V and prothrombin gene polymorphisms. Gematologija i transfuziologija. 2018; 3: 250–7. doi: 10.25837/HAT.2019.63.13.004 (in Russian)].
  10. Miranda-Vilela A.L. Role of polymorphisms in factor V (FV Leiden), prothrombin, plasminogen activator inhibitor type-1 (PAI-1), methylenetetrahydrofolate reductase (MTHFR) and cystathionine-synthase (CBS) genes as risk factors for thrombophilias. Mini Rev. Med. Chem. 2012; 12: 997–1006. doi: 10.2174/138955712802762338.
  11. Мудров В.А. Алгоритмы статистического анализа качественных признаков в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020; 1: 151–63. doi: 10.52485/19986173_2020_1_151. [Mudrov V.A. Algorithms for statistical analysis of qualitative features in biomedical research using the SPSS software package. Zabajkal’skij medicinskij vestnik. 2020; 1: 151–63. doi: 10.52485/19986173_2020_1_151. (in Russian)].
  12. Аит А.А., Азова М.М., Гигани О.О., Гигани О.Б., Благонравов М.Л. Встречаемость полиморфизма Leu33Pro гена ITGB3 в выборках из популяций Алжира, Сирии и Центральной России. Auditorium. 2016; 2 (10): 20–3. [Ait A.A., Azova M.M., Gigani O.O., Gigani O.B., Blagonravov M.L. Occurrence of the Leu33Pro polymorphism of the ITGB3 gene in samples from the populations of Algeria, Syria, and Central Russia. Auditorium. 2016; 2 (10): 20–3 (in Russian)].
  13. Мяндина Г.И., Зотова Т.Ю., Вареха Л.А., Касапова Е.Н. Полиморфизмы генов ITGB3 и протромбина среди пациентов с дислипидемиями, страдающих гипертонической болезнью и ишемической болезнью сердца. Здоровье и образование в XXI веке. 2014; 16 (4): 56–9. [Mjandina G.I., Zotova T.Ju., Vareha L.A., Kasapova E.N. Polymorphisms of the ITGB3 and prothrombin genes among patients with dyslipidemias, suffering from hypertension and coronary heart disease. Zdorov’e i obrazovanie v XXI veke. 2014; 16 (4): 56–9 (in Russian)].
  14. Богатырева К.Б., Азова М.М., Агаджанян А.В., Цховребова Л.В., Аит А.А., Шугушев З.Х. Ассоциация полиморфизма T1565C гена ITGB3 с развитием атеросклероза и ин-стент рестеноза коронарных артерий у пациентов со стабильной ишемической болезнью сердца. Научные результаты биомедицинских исследований. 2018; 4 (4): 3–9. doi: 10.18413/2313-8955-2018-4-4-0-1. [Bogatyreva K.B., Azova M.M., Agadzhanjan A.V., Chovrebova L.V., Ait A.A., Shugushev Z.H. Association of polymorphism T1565C of the ITGB3 gene with the development of atherosclerosis and in-stent restenosis of the coronary arteries in patients with stable ischemic heart disease. Nauchnye rezul’taty biomedicinskih issledovanij. 2018; 4 (4): 3–9. doi: 10.18413/2313-8955-2018-4-4-0-1 (in Russian)].
  15. Сибирева О.Ф., Хитринская Е.Ю., Калюжин В.В., Сазонов А.Э., Иванчук И.И., Гранкина В.Ю. Полиморфизм генов II, V факторов свертывания крови и метилентетрагидрофолатредуктазы у больных с диабетической нефропатией: распространенность, клиническое и прогностическое значение. Сахарный диабет. 2010; 1: 6–9. [Sibireva O.F., Hitrinskaja E.Ju., Kaljuzhin V.V., Sazonov A.Je., Ivanchuk I.I., Grankina V.Ju. Polymorphism of genes II, V of blood coagulation factors and methylenetetrahydrofolate reductase in patients with diabetic nephropathy: prevalence, clinical and prognostic significance. Saharnyj diabet. 2010; 1: 6–9 (in Russian)].
  16. Rahimi Z., Felehgari V., Rahimi M., Mozafari H., Yari K., Vaisi-Raygani A., Rezaei M., Malek-Khosravi S., Khazaie H. The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Molecular biology reports. 2011; 38 (3): 2117–23. DOI: 10.1007 / s11033-010-

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies